ORIC
Oric Pharmaceuticals Inc
13.20$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -3.1% | -2.3% | +5.5% | +9.6% | -1.6% | -10.5% | +11.8% | +2.4% | +2.4% | -0.8% | +2.3% | -0.8% | +4.2% | -0.7% | +12.6% | -0.7% | +2.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.3% | +11.7% | +23.6% | +4.2% | +6.5% | +14.3% | +37.2% | -3.4% | +32.7% | -16.9% | +29.8% | +0.5% | -17.8% | +6.4% | +10.7% | +19.8% | -3.7% | +19.2% | +9.3% | -10.3% | +31.8% | +7.8% | +2.5% | -22.9% | +24.0% | -5.8% | -10.1% | +21.6% | +15.5% | – | |
| – | +16.0% | +11.4% | +23.6% | +6.3% | +76.6% | +11.8% | +13.1% | +13.0% | +14.1% | +0.3% | +9.1% | +6.1% | +6.7% | -13.0% | -2.5% | +5.8% | +0.7% | +1.4% | +10.4% | +1.2% | +0.7% | +0.6% | +6.8% | +6.3% | +5.4% | -7.2% | +10.1% | -5.9% | +10.0% | – | |
| – | +0.1% | +11.7% | +23.6% | +1.8% | +24.6% | +130.2% | +10.5% | -41.5% | +27.2% | -12.4% | +23.6% | +2.0% | -11.0% | +24.1% | -13.9% | +16.1% | -2.7% | +14.8% | +8.7% | -7.8% | +25.4% | +6.4% | +2.5% | -16.7% | +19.4% | -6.1% | -6.7% | +15.7% | +13.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +49.4% | +40.5% | -23.9% | -42.2% | -89.6% | -60.0% | +200.0% | +46.7% | -25.0% | -9.1% | +13.3% | +191.2% | +313.1% | +111.5% | +47.1% | +56.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -287.7% | – | -90.3% | -224.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.